Three-dimensional structure of a gamma-carboxyglutamic acid-containing conotoxin, conantokin G, from the marine snail Conus geographus: the metal-free conformer

Biochemistry
A C RigbyBarbara C Furie

Abstract

Conantokin G is a gamma-carboxyglutamic acid-containing conotoxin from the venom of the marine cone snail Conus geographus. The 17-residue peptide, which contains five gamma-carboxyglutamic acid (Gla) residues and an amidated C-terminal asparagine amide, was synthesized chemically in a form identical to the natural conantokin G. To gain insight into the role of gamma-carboxyglutamic acid in the structure of this peptide, we determined the three-dimensional structure of conantokin G by 1H NMR and compared its structure to other conotoxins and to the gamma-carboxyglutamic acid-containing regions of the vitamin K-dependent blood-clotting proteins. Complete resonance assignments were made by two-dimensional 1H NMR spectroscopy in the absence of metal ions. NOE cross-peaks d(alphaN), d(NN), and d(betaN) provided interproton distance information, and vicinal spin-spin coupling constants 3J(HN alpha) were used to calculate phi torsion angles. Distance geometry and simulated annealing methods were used to derive 20 convergent structures from a set of 227 interproton distance restraints and 13 torsion angle measurements. The backbone rmsd to the geometric average for 20 final structures is 0.8 +/- 0.1 A. Conantokin G consists of a struc...Continue Reading

References

May 1, 1992·Journal of Biomolecular NMR·S Ludvigsen, F M Poulsen
Nov 20, 1991·Journal of Molecular Biology·D S WishartF M Richards
Jul 1, 1989·Physiological Reviews·P V HauschkaC M Gundberg
Mar 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J W Suttie
Jan 1, 1995·Annual Review of Nutrition·C VermeerM H Knapen
Jan 24, 1997·The Journal of Biological Chemistry·N SkjaerbaekD J Craik

❮ Previous
Next ❯

Citations

Jun 4, 1999·Progress in Biophysics and Molecular Biology·D D SchlaepferD J Sieg
Feb 17, 2000·Drug Discovery Today·G S ShenR T McCabe
Sep 22, 1999·European Journal of Biochemistry·A G CraigB M Olivera
Jun 29, 2000·Annual Review of Biochemistry·J M McIntoshB M Olivera
Jul 16, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·T BlandlF J Castellino
Apr 1, 2007·Expert Opinion on Drug Discovery·Marianne A GrantAlan C Rigby
May 20, 2003·The Journal of Peptide Research : Official Journal of the American Peptide Society·R C KleinF J Castellino
Mar 1, 2005·Toxicon : Official Journal of the International Society on Toxinology·Yu-Hong HanCheng-Wu Chi
Jun 15, 2004·Biochemical and Biophysical Research Communications·Karin HanssonJohan Stenflo
Sep 6, 2006·Toxicon : Official Journal of the International Society on Toxinology·Raymond S Norton, Baldomero M Olivera
Aug 6, 1999·Protein Engineering·C H LinP C Lyu
Oct 19, 2001·Oncogene·M D Schaller
Nov 30, 2000·The Journal of Biological Chemistry·T BlandlF J Castellino
Jan 13, 2004·Physiological Reviews·Heinrich Terlau, Baldomero M Olivera
Apr 16, 1998·The Journal of Biological Chemistry·P K BandyopadhyayB M Olivera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.